In: Nursing
In a study concerning the relationship between the use of exogenous estrogens and subsequent risk of breast cancer, a sample of 1000 pre-menopausal women was followed for 8 years. The results are presented in the table below.
Breast Cancer |
|||
Estrogen Therapy |
Present |
Absent |
Total |
+ |
300 |
200 |
500 |
- |
100 |
400 |
500 |
Total |
400 |
600 |
1000 |
1.What kind of study is this?
2.Is this study prospective or retrospective?
3.The cumulative incidence of breast cancer among women receiving estrogen therapy is:
4.The cumulative incidence of breast cancer among women who did not receive estrogen therapy is:
5.The relative risk associated with estrogen therapy in this study is:
Answer 1
Answer is Option "d" .. COHORT STUDY
As the study is undertaken before the onset of disease and the proceeds from exposure to outcome its a cohort study, as the disease has not occurred at the time of start of study.
Why the answer is Cohort study-
COHORT STUDY is a type of analytical study undertaken to refute or support the existence of association between suspected cause and disease. The study proceeds from Exposure to outcome
Also known as PROSPECTIVE STUDY/ INCIDENCE STUDY/ FORWARD LOOKING STUDY.
Distinguishing features are-
CASE CONTROL STUDY
Also called as Retrospective study
It is an Analytical study design
These are first approach to test casual hypothesis .
Distinguishing features are-
CROSS SECTIONAL STUDY
It is the simplest form of an observational study based on single examination of a cross section of population at one point of time.
Also called Prevalence study
ECOLOGICAL STUDY
They are type of descriptive studies
Group is the unit of study with no individual level of information on the distribution of exposure and disease.
ANSWER 2
Option " a"
It is a prospective study design ad it proceeds from
Exposure to outcome.
Answer 3
Cumulative incidence of Breast cancer among females receiving estrogen therapy-
CUMULATIVE INCIDENCE
= number of new cases
Population at risk
=cases developed after taken Estrogen therapy
Population receiving therapy
= 300/500
= 0.6
Answer - 0.6
ANSWER 4
Cumulative incidence of Breast cancer among females not receiving estrogen therapy-
= Female who developed breast cancer and were not on therapy / population at risk
= 100/ 500
= 0.2
Answer - 0.2
ANSWER 5
Relative risk= Incidence of disease in exposed
Incidence of disease in non exposed
Incidence of disease in exposed = 300/500
As 300 females developed breast cancer and were on estrogen therapy and total females in study with estrogen therapy are 500
Incidence of disease in non exposed = 100/500
As 100 females did not receive estrogen therapy but they developed breast cancer. Total females who did not receive therapy is 500
Relative risk = 300/100
= 3
Answer- Relative risk is 3